Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Kvien, T.

Refine Results

Resource Type

Availability

Creation Date

Faculty

Collection

Author

Show more

Language

Search results

  • RSS Feed
(1 - 8 of 8)
Disease Course in Seronegative RA Patients Classified According to the 2010 ACR/EULAR Criteria
Nordberg, L.B.; Lillegraven, S.; Aga, A.B.; Olsen, I.C.; Lie, E.; Hammer, H.B.; ... ; Haavardsholm, E.A. 2017
Disease Course in Seronegative RA Patients Classified According to the 2010 ACR/EULAR Criteria
Article / Letter to editor
metadata only
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Smolen, J.S.; Landewe, R.; Bijlsma, J.; Burmester, G.; Chatzidionysiou, K.; Dougados, M.; ... ; Heijde, D. van der 2017
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Article / Letter to editor
metadata only
Defining cut-off values for disease activity states and improvement scores for patient-reported outcomes: the example of the Rheumatoid Arthritis Impact of Disease (RAID)
Dougados, M.; Brault, Y.; Logeart, I.; Heijde, D. van der; Gossec, L.; Kvien, T. 2012
Defining cut-off values for disease activity states and improvement scores for patient-reported outcomes: the example of the Rheumatoid Arthritis Impact of Disease (RAID)
Article / Letter to editor
metadata only
RADIOGRAPHIC JOINT SPACE NARROWING, MALALIGNMENT AND CLINICAL SOFT TISSUE SWELLING ARE ASSOCIATED WITH MRI-DEFINED BONE MARROW LESIONS IN HAND OSTEOARTHRITIS
Haugen, I.K.; Boyesen, P.; Slatkowsky-Christensen, B.; Sesseng, S.; Heijde, D. van der; Kvien, T. 2012
RADIOGRAPHIC JOINT SPACE NARROWING, MALALIGNMENT AND CLINICAL SOFT TISSUE SWELLING ARE ASSOCIATED WITH MRI-DEFINED BONE MARROW LESIONS IN HAND OSTEOARTHRITIS
Article / Letter to editor
metadata only
Time to and Level of Initial DAS28 Change With Certolizumab Pegol Predicts the Likelihood of Having Low Disease Activity at Years 1 and 2 in Patients With Rheumatoid Arthritis
Haraoui, B.; Heijde, D. van der; Schiff, M.; Keystone, E.; Landewe, R.; Kvien, T.; ... ; Furst, D. 2011
Time to and Level of Initial DAS28 Change With Certolizumab Pegol Predicts the Likelihood of Having Low Disease Activity at Years 1 and 2 in Patients With Rheumatoid Arthritis
Other
metadata only
PROBABILITY OF ACHIEVING LOW DISEASE ACTIVITY AT 52 WEEKS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH CERTOLIZUMAB PEGOL DEPENDS ON TIME TO AND LEVEL OF INITIAL RESPONSE
Heijde, D. van der; Schiff, M.; Keystone, E.; Landewe, R.; Kvien, T.; Curtis, J.; ... ; Furst, D. 2011
PROBABILITY OF ACHIEVING LOW DISEASE ACTIVITY AT 52 WEEKS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH CERTOLIZUMAB PEGOL DEPENDS ON TIME TO AND LEVEL OF INITIAL RESPONSE
Other
metadata only
DKK1, AN INHIBITOR OF BONE FORMATION IS AN INDEPENDENT PREDICTOR OF HAND BONE LOSS IN RHEUMATOID ARTHRITIS
Grandaunet, B.; Syversen, S.; Hoff, M.; Haugeberg, G.; Heijde, D. van der; Kvien, T.; Standal, T. 2010
DKK1, AN INHIBITOR OF BONE FORMATION IS AN INDEPENDENT PREDICTOR OF HAND BONE LOSS IN RHEUMATOID ARTHRITIS
Other
metadata only
Open-Label Certolizumab Pegol Is Effective In Patients Who Withdrew From Double-Blind Treatment Due To Non-Response
Keystone, E.; Heijde, D. van der; Smolen, J.; Weinblatt, M.; Kvien, T.; Strand, V.; ... ; Combe, B. 2010
Open-Label Certolizumab Pegol Is Effective In Patients Who Withdrew From Double-Blind Treatment Due To Non-Response
Other
metadata only